49
Participants
Start Date
December 31, 2012
Primary Completion Date
October 31, 2023
Study Completion Date
October 31, 2023
Romidepsin
Romidepsin will be administered intravenously on days 1, 8, and 15 of a 28-day cycle.
Lenalidomide
Lenalidomide will be taken orally daily for 21 days of a 28-day cycle.
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center at Mercy, Rockville Centre
Memorial Sloan Kettering Cancer Center at Commack, Commack
Saint Francis/Mount Sinai Regional Cancer Center, Hartford
University of Nebraska Medical Center, Omaha
Memorial Sloan Kettering at Basking Ridge, Basking Ridge
Weill Cornell Medical Center, New York
Collaborators (2)
St. Francis Hospital & Medical Center, Hartford CT
OTHER
Weill Medical College of Cornell University
OTHER
University of Nebraska
OTHER
Celgene Corporation
INDUSTRY
Biologics, Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER